Industry 4.0 is a concept that represents the adoption by industry of techniques and processes allowed by digitisation, cloud computing, the internet of things and big data to gain competitive advantages in domestic and global markets. The research is conducted in Ireland with the resulting data examined through a global lens, yielding information relevant to the effective adoption and integration of 4.0 concepts. Key outcomes are the perspectives of the pharmaceutical and biopharmaceutical industries with regards to the adoption of 4.0, the current level of implementation of 4.0 technologies in manufacturing facilities and planned 4.0 projects to be executed. Statistically relevant relationships evident in the responses are also investigated. This research provides novel and highly relevant information concerning the state of industry preparedness for the adoption of 4.0.

Across all survey respondents only 42% indicated any knowledge of 4.0. The majority of respondents who indicated a knowledge of 4.0 identified with either the Automation or Engineering department. Among established employees with greater than 8 years of experience 82% identified with having knowledge of 4.0. Those surveyed with Vice-President or Director roles, had a 98% certainty of 4.0 awareness. A noteworthy finding of this work is the identification of a substantial disconnect in knowledge of 4.0 based on seniority, function and industry. Thus while the implementation of 4.0 is playing an increasingly significant role in the modernisation of the Pharmaceutical and Biopharmaceutical industries, challenges remain with respect to the holistic fusion of 4.0 into the culture of organisations.

工业4.0是代表行业采用数字化，云计算，物联网和大数据所允许的技术和流程以在国内和全球市场上获得竞争优势的概念。这项研究是在爱尔兰进行的，其结果数据通过全球角度进行了审查，得出了与有效采用和整合4.0概念相关的信息。关键成果是制药和生物制药行业对采用4.0的观点，制造设施中4.0技术的当前实施水平以及计划中要执行的4.0项目。还对响应中明显的统计相关关系进行了调查。

在所有调查受访者中，只有42％的人表示对4.0有任何了解。表示对4.0的了解的大多数受访者与自动化或工程部门联系在一起。在具有8年以上经验的老员工中，有82％的员工具有4.0的知识。接受副总裁或董事职位调查的人对4.0意识的把握率为98％。这项工作的一个值得注意的发现是，根据资历，职能和行业确定了4.0知识的重大脱节。因此，尽管4.0的实施在制药和生物制药行业的现代化中起着越来越重要的作用，但将4.0整体融合到组织文化中仍然面临挑战。